Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca Pulk

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 25, 2018
Utilizing big data to provide better health at lower costLaney K Jones, Rebecca Pulk, Michael R Gionfriddo, et al.
Frontiers in Big Data|December 2, 2022
Pharmacogenomics driven decision support prototype with machine learning: A framework for improving patient careFarah Kidwai-Khan, Christopher T Rentsch, Rebecca Pulk, et al.
Proteins|December 1, 2010
A new regulatory switch in a JAK protein kinaseVickie Tsui, Paul Gibbons, Mark Ultsch, et al.
Bioorganic & Medicinal Chemistry Letters|August 26, 2009
Identification of orally bioavailable, non-amidine inhibitors of Urokinase Plasminogen Activator (uPA)Christopher W West, Marc Adler, Danny Arnaiz, et al.
Clinical Pharmacology and Therapeutics|December 1, 2018
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for the Use of Potent Volatile Anesthetic Agents and Succinylcholine in the Context of RYR1 or CACNA1S GenotypesStephen G Gonsalves, Robert T Dirksen, Katrin Sangkuhl, et al.
Journal of Medicinal Chemistry|May 1, 2009
A class of 2,4-bisanilinopyrimidine Aurora A inhibitors with unusually high selectivity against Aurora BIgnacio Aliagas-Martin, Dan Burdick, Laura Corson, et al.
AIDS and Behavior|October 28, 2024
The Feasibility and Acceptability of a Clinical Pharmacist-delivered Intervention to Reduce Bothersome Health Symptoms from Polypharmacy and Alcohol Use and Communicate Risk among People with HIV: Pilot Study ProtocolJulie A Womack, Micaela M Leblanc, Annette S Sager, et al.
Bioorganic & Medicinal Chemistry Letters|July 23, 2013
2-Amino-[1,2,4]triazolo[1,5-a]pyridines as JAK2 inhibitorsMichael Siu, Richard Pastor, Wendy Liu, et al.
Journal of Biomolecular Screening|April 1, 2005
Differential inhibition of inducible T cell cytokine secretion by potent iron chelatorsStewart Leung, April Holbrook, Beverly King, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2012
Structure-based discovery of C-2 substituted imidazo-pyrrolopyridine JAK1 inhibitors with improved selectivity over JAK2Sharada Labadie, Peter S Dragovich, Kathy Barrett, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 25, 2018
Utilizing big data to provide better health at lower costLaney K Jones, Rebecca Pulk, Michael R Gionfriddo, et al.
Frontiers in Big Data|December 2, 2022
Pharmacogenomics driven decision support prototype with machine learning: A framework for improving patient careFarah Kidwai-Khan, Christopher T Rentsch, Rebecca Pulk, et al.
Proteins|December 1, 2010
A new regulatory switch in a JAK protein kinaseVickie Tsui, Paul Gibbons, Mark Ultsch, et al.
Bioorganic & Medicinal Chemistry Letters|August 26, 2009
Identification of orally bioavailable, non-amidine inhibitors of Urokinase Plasminogen Activator (uPA)Christopher W West, Marc Adler, Danny Arnaiz, et al.
Clinical Pharmacology and Therapeutics|December 1, 2018
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for the Use of Potent Volatile Anesthetic Agents and Succinylcholine in the Context of RYR1 or CACNA1S GenotypesStephen G Gonsalves, Robert T Dirksen, Katrin Sangkuhl, et al.
Journal of Medicinal Chemistry|May 1, 2009
A class of 2,4-bisanilinopyrimidine Aurora A inhibitors with unusually high selectivity against Aurora BIgnacio Aliagas-Martin, Dan Burdick, Laura Corson, et al.
AIDS and Behavior|October 28, 2024
The Feasibility and Acceptability of a Clinical Pharmacist-delivered Intervention to Reduce Bothersome Health Symptoms from Polypharmacy and Alcohol Use and Communicate Risk among People with HIV: Pilot Study ProtocolJulie A Womack, Micaela M Leblanc, Annette S Sager, et al.
Bioorganic & Medicinal Chemistry Letters|July 23, 2013
2-Amino-[1,2,4]triazolo[1,5-a]pyridines as JAK2 inhibitorsMichael Siu, Richard Pastor, Wendy Liu, et al.
Journal of Biomolecular Screening|April 1, 2005
Differential inhibition of inducible T cell cytokine secretion by potent iron chelatorsStewart Leung, April Holbrook, Beverly King, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2012
Structure-based discovery of C-2 substituted imidazo-pyrrolopyridine JAK1 inhibitors with improved selectivity over JAK2Sharada Labadie, Peter S Dragovich, Kathy Barrett, et al.
Pageof 2